Evaluation of the donor liver for living donor liver transplantation

被引:47
作者
Brandhagen, D [1 ]
Fidler, J [1 ]
Rosen, C [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Transplant Ctr, Rochester, MN 55905 USA
关键词
D O I
10.1053/jlts.2003.50222
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Key Points 1. Accurate assessment of the donor liver is an important component of the living donor liver evaluation and is critical to ensure a successful outcome for both donor and recipient. 2. Liver biochemistry tests, viral hepatitis serological tests, tests to exclude chronic liver disease, and volumetric computed tomographic or magnetic resonance (MR) imaging of the liver are performed routinely as part of the donor evaluation. 3. Liver biopsy should be a standard component of the donor evaluation in all donors, with the possible exception of those with a body mass index less than 25 who have normal liver test and abdominal imaging study results and no risk factors for chronic liver disease or hepatic steatosis. 4. The maximum acceptable percentage of steatosis in the donor liver is unknown, but most centers use an upper limit of 10% to 30%. 5. A graft-recipient body weight ratio of at least 0.8% provides the recipient with adequate hepatic mass in most situations. 6. Anatomic variants in donor biliary and hepatic vascular anatomy are common. 7. Evaluation of donor vascular anatomy varies among centers and includes MR or computed tomographic angiography and hepatic angiography. 8. Evaluation of biliary anatomy is performed most commonly using intraoperative cholangiography. Some centers use MR cholangiography or endoscopic retrograde cholangiopancreatography in selected situations.
引用
收藏
页码:S16 / S28
页数:13
相关论文
共 83 条
  • [1] Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
    Angulo, P
    Keach, JC
    Batts, KP
    Lindor, KD
    [J]. HEPATOLOGY, 1999, 30 (06) : 1356 - 1362
  • [2] BANERJI MA, 1995, INT J OBESITY, V19, P846
  • [3] Use of imaging for living donor liver transplantation
    Bassignani, MJ
    Fulcher, AS
    Szucs, RA
    Chong, WK
    Prasad, UR
    Marcos, A
    [J]. RADIOGRAPHICS, 2001, 21 (01) : 39 - 52
  • [4] MRI evaluation of the liver
    Beavers, KL
    Semelka, RC
    [J]. SEMINARS IN LIVER DISEASE, 2001, 21 (02) : 161 - 177
  • [5] Hepatic Steatosis as a Potential Risk Factor for Major Hepatic Resection
    Behrns K.E.
    Tsiotos G.G.
    DeSouza N.F.
    Krishna M.K.
    Ludwig J.
    Nagorney D.M.
    [J]. Journal of Gastrointestinal Surgery, 1998, 2 (3) : 292 - 298
  • [6] Prevalence of and risk factors for hepatic steatosis in northern Italy
    Bellentani, S
    Saccoccio, G
    Masutti, F
    Crocè, LS
    Brandi, G
    Sasso, F
    Cristanini, G
    Tiribelli, C
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (02) : 112 - 117
  • [7] Accuracy and utility of 3-dimensional computed tomography in evaluating donors for adult living related liver transplants
    Bogetti, JD
    Herts, BR
    Sands, MJ
    Carroll, JF
    Vogt, DP
    Henderson, JM
    [J]. LIVER TRANSPLANTATION, 2001, 7 (08) : 687 - 692
  • [8] The spectrum of nonalcoholic fatty liver disease with normal liver enzymes
    Brandhagen, DJ
    Douglas, DD
    Poterucha, JJ
    Burgart, LJ
    Rosen, CB
    Mulligan, DC
    Lindor, KD
    Wiesner, RH
    Angulo, P
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A717 - A718
  • [9] A survey of liver transplantation from living adult donors in the United States
    Brown, RS
    Russo, MW
    Lai, M
    Shiffman, ML
    Richardson, MC
    Everhart, JE
    Hoofnagle, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09) : 818 - 825
  • [10] Cheng YF, 2001, TRANSPLANTATION, V72, P1527